Rick Gonzalez, AbbVie CEO (Pablo Martinez Monsivais/AP Images)
The pharma world's champion patent wall builder is called out for their 'drip-feed' strategy to safeguard the next megablockbuster franchise
By all accounts, AbbVie holds the title as a master builder of patent walls. Its work on Humira has been both legendary and extraordinarily …
